跳至主要内容
临床试验/NCT04838067
NCT04838067已完成不适用

Validation of Therapeutic Effects of Cefaly on Insomnia by Neuroimaging and Polysomnography Analyses: a Single Site, Single-armed Exploratory Study

Saint Vincent's Hospital, Korea2 个研究点 分布在 2 个国家目标入组 19 人开始时间: 2018年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
19
试验地点
2
主要终点
Insomnia severity index(ISI)

研究概览

简要总结

The study aims to examine whether the Cefaly has a therapeutic effect on insomnia patients visiting a psychiatric clinic in Korea. The study design is a single site, single-armed exploratory study. Insomnia patients received a 20-minute daily sessions of the Cefaly for 4 weeks. Primary endpoint was a reduction of scores in Pittsburgh Sleep Quality Index, Insomnia Severity Index, Epworth Sleepiness Scale, improvements in polysomnography measures, and changes in resting state networks, cortical thickness, fractional anisotropy and mean diffusivity

详细描述

Insomnia is well-known for its association with adverse health outcomes. Although insomnia is usually treated with hypnotics or cognitive behavioral therapy for insomnia, the need for novel nonpharmacological treatment for insomnia is increasing emphasized due to reports of side effects and detrimental consequences of hypnotics. Trigeminal nerve electrical neuromodulation has been suggested as a potential treatment modality through its modulation of noradrenergic activity that results in promoting relaxation and reducing hyperarousal. Insomnia patients enrolled in the study will go through a 20-minute daily session of the Cefaly device(originally FDA-approved device for migraine, which electrically modulates trigeminal nerve) for 4 weeks. The objective of this study is to test whether trigeminal nerve electrical neuromodulation has a therapeutic effect, validation measures involving subjective measures(Pittsburgh Sleep Quality Index, Insomnia Severity Index, Epworth Sleepiness Scale), objective measures(Polysomnography measures) and neuroimaging(changes in resting state networks, cortical thickness, fractional anisotropy and mean diffusivity).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have adequately understood the whole study procedures within age range of 19-64 years
  • Patients with insomnia severity index (ISI) score of more than 15

排除标准

  • Cognitive impairment
  • Psychiatric disorders or neurological disorders.
  • Unstable medical conditions
  • Prior diagnosis of sleep disorders
  • Hypnotic prescription
  • History of brain or facial trauma within 3 months
  • Skin abrasions
  • Acrylic acid allergy
  • Electromagnetic hypersensitivity
  • Apnea hypopnea index of >15/hour in the baseline polysomnography.

结局指标

主要结局

Insomnia severity index(ISI)

时间窗: 4 weeks after intervention

Changes in Insomnia severity index scores ISI is a brief, self-rated scale that is widely used to measure insomnia severity. With seven items scored on a 0-4 scale, it only takes about 5 minutes to complete and scores of 15 or more indicates insomnia of moderate to severe severity.

Pittsburgh sleep quality index(PSQI)

时间窗: 4 weeks after intervention

Changes in Pittsburgh sleep quality index scores PSQI global score of more than 5 signifies major sleep disturbance, higher scores suggesting greater sleep disturbance.

Epworth sleepiness scale(ESS)

时间窗: 4 weeks after intervention

Changes in Epworth sleepiness scale scores Score of more than 10 signifies clinically meaningful daytime sleepiness, with higher scores indicating more severe sleepiness.

Polysomnography measures-1 (Total sleep time)

时间窗: 4 weeks after intervention

Changes in Total sleep time

Polysomnography measures-4(Stage 2 sleep period)

时间窗: 4 weeks after intervention

Changes in Stage 2 sleep period

Polysomnography measures-2 (Wake after sleep onset)

时间窗: 4 weeks after intervention

Changes in Wake after sleep onset

Polysomnography measures-3( Stage 1 sleep period)

时间窗: 4 weeks after intervention

Changes in Stage 1 sleep period

Polysomnography measures-5(Stage 3 sleep period)

时间窗: 4 weeks after intervention

Changes in Stage 3 sleep period

Polysomnography measures-8(Sleep latency)

时间窗: 4 weeks after intervention

Changes in Sleep latency

Polysomnography measures-6(Total rapid eye movement sleep period)

时间窗: 4 weeks after intervention

Changes in Total rapid eye movement sleep period

Polysomnography measures-7(Rapid eye movement sleep latency)

时间窗: 4 weeks after intervention

Changes in Rapid eye movement sleep latency

Polysomnography measures-9(Apnea hypopnea index)

时间窗: 4 weeks after intervention

Changes in Apnea hypopnea index

Neuroimaging parameter changes-2(Cortical thickness)

时间窗: 4 weeks after intervention

Changes in Cortical thickness

Neuroimaging parameter changes-4(Fractional anisotropy)

时间窗: 4 weeks after intervention

Changes in Fractional anisotropy

Neuroimaging parameter changes-5(Mean diffusivity)

时间窗: 4 weeks after intervention

Changes in Mean diffusivity

Neuroimaging parameter changes-1(Resting state network functional connectivity)

时间窗: 4 weeks after intervention

Resting state network functional connectivity changes

次要结局

未报告次要终点

研究者

发起方
Saint Vincent's Hospital, Korea
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yoo Hyun Um

Clinical Assistant Professor

Saint Vincent's Hospital, Korea

研究点 (2)

Loading locations...

相似试验